Detalles de la búsqueda
1.
Evaluation of the impact of night shift work on disease severity in psoriatic patients: a case-control study with clinical, hormonal, and immunological evaluation.
Dermatology
; 2024 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38889692
2.
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.
J Eur Acad Dermatol Venereol
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38860729
3.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
J Eur Acad Dermatol Venereol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284131
4.
Atopic Dermatitis in the Elderly Population.
Acta Derm Venereol
; 103: adv13363, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38095061
5.
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Eur Acad Dermatol Venereol
; 37(5): 1017-1027, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695061
6.
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.
J Eur Acad Dermatol Venereol
; 37(1): 123-136, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36018221
7.
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry.
J Eur Acad Dermatol Venereol
; 37(2): 365-381, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169355
8.
Successful use of anti-IL-23 molecules in overweight-to-obese psoriatic patients: A multicentric retrospective study.
Dermatol Ther
; 35(11): e15793, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36038527
9.
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients.
Dermatology
; 238(4): 717-724, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34710866
10.
Pediatric Hidradenitis Suppurativa: A Cross-Sectional Study on Clinical Features and Treatment Approaches.
J Cutan Med Surg
; 26(2): 127-134, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34615396
11.
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis?
Int J Mol Sci
; 23(21)2022 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36361639
12.
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry.
Allergy
; 76(6): 1813-1824, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152613
13.
Real-Time Confocal Imaging for Hidradenitis Suppurativa: Description of Morphological Aspects and Focus on the Role of Follicular Ostia.
Dermatology
; 237(5): 705-711, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588411
14.
Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Dermatology
; 237(5): 759-768, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326954
15.
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy.
Dermatology
; 237(4): 535-541, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33477153
16.
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Acta Derm Venereol
; 101(3): adv00422, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269404
17.
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
Acta Derm Venereol
; 101(10): adv00576, 2021 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903916
18.
Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice.
Pharmacol Res
; 158: 104878, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417503
19.
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.
J Am Acad Dermatol
; 83(1): 39-45, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32229281
20.
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis.
Dermatology
; 236(4): 329-335, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369808